on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake Disclosure in Mural Oncology
The Vanguard Group, Inc. has disclosed its position regarding Mural Oncology plc in a regulatory filing dated June 17, 2025. According to Form 8.3 submitted to the Irish Takeover Panel, The Vanguard Group holds 773,091 ordinary shares of Mural Oncology, representing a 4.48% interest in the company.
Classified as $0.01 ordinary shares, The Vanguard Group engaged in recent securities transactions, purchasing 48 shares and selling 16, each at a price of 2.44 USD. No cash-settled or stock-settled derivatives or related agreements were reported. Additionally, there are no indemnity or option arrangements, nor are there any voting agreements or plans for future security acquisitions or disposals.
This disclosure is part of the requirements under the Irish Takeover Panel Act of 1997 and the 2022 Takeover Rules, aimed at maintaining transparency concerning significant interests in relevant securities.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news